NCT06057675View on ClinicalTrials.gov

Tranexamic Acid in Nasal Mohs Reconstruction

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Postoperative BleedingSkin Cancer Face
Interventions
DRUG

Treatment (tranexamic acid and 1% lidocaine with 1:100,000 epinephrine)

Subcutaneous injection of local anesthetic (1% lidocaine with 1:100,000 epinephrine) and tranexamic acid (1g/10mL), mixed in a 9:1 volume ratio.

DRUG

Control (1% lidocaine with 1:100,000 epinephrine)

Subcutaneous injection of local anesthetic (1% lidocaine with 1:100,000 epinephrine)

Trial Locations (1)

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER